P-21 – Synthetic Neuropeptide Analog (Research Use Only)
Lyophilized Powder for In Vitro Laboratory Applications
Product Overview
P-21 is a synthetic neuropeptide analog studied in in vitro and preclinical research models exploring cognitive signaling pathways, synaptic regulation, and peptide–receptor interactions. This compound is provided in high-purity lyophilized form and is intended strictly for controlled laboratory research.
Each batch is verified by third-party HPLC testing to ensure purity and identity, supporting reproducible experimental outcomes in non-clinical environments.
Product Specifications
Attribute | Details |
---|---|
Peptide Name | P-21 |
Classification | Synthetic neuropeptide analog |
Form | Lyophilized peptide powder |
Purity | ≥98% (HPLC-verified) |
Solubility | Soluble in sterile bacteriostatic water |
Packaging | Sterile glass vial with tamper-evident seal |
Storage | Store at –20°C in a dry, dark environment |
Shelf Life | Up to 24 months unopened |
Intended Use | In vitro and preclinical laboratory research only |
Research Applications
P-21 is utilized in:
- Receptor Binding Assays: Evaluation of neuropeptide interaction with receptor sites in cellular models
- Cognitive Signaling Pathway Research: Preclinical assays involving learning, memory, and synaptic function markers
- Neurobiological Pathway Modeling: Studies exploring peptide activity in relation to neuronal plasticity
- Mechanistic Neuroprotection Studies: Investigations of cellular resilience and repair processes under induced stress
- All uses are investigational and conducted under qualified supervision in lab-only settings.
Handling & Usage Guidelines
- Reconstitute in sterile conditions using approved lab-grade solvents
- Do not ingest, inject, or apply to any living organism
- Store reconstituted solution under refrigeration (2–8°C) and avoid repeated freeze–thaw cycles
- Use within institutional safety and documentation protocols
Not approved for human or veterinary use. Laboratory research use only.
There are no reviews yet.